November 1, 2016
Pfizer to discontinue two ongoing cardiovascular studies
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…
Pharmaceuticals, Biotechnology and Life Sciences
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…